Market overview
The global biospecimen logistics market is worth USD 3.9 bn in 2026 and is forecast to reach USD 9.3 bn by 2036, growing at a 9.0% CAGR. United States is the largest country market and Transport and courier is the largest by service segment.
| Scope | Temperature-controlled transport, storage and handling of blood, tissue, DNA and other biological samples between trial sites, laboratories and biobanks. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 3.6 bn |
| Value 2026 | USD 3.9 bn |
| Value 2036 | USD 9.3 bn |
| CAGR 2026-2036 | 9.0% |
| Volume 2026 | 25.6 million shipments |
| Volume 2036 | 49.8 million shipments |
| Average price 2026 | USD 153 per shipment |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Biospecimen Logistics market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 3.9 bn |
| 2027 | USD 4.3 bn |
| 2028 | USD 4.7 bn |
| 2029 | USD 5.1 bn |
| 2030 | USD 5.5 bn |
| 2031 | USD 6.0 bn |
| 2032 | USD 6.6 bn |
| 2033 | USD 7.2 bn |
| 2034 | USD 7.8 bn |
| 2035 | USD 8.5 bn |
| 2036 | USD 9.3 bn |
Biospecimen Logistics market segmentation
By service
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Transport and courier | 54.0% | 52.9% | USD 2.1 bn | 8.8% |
| Biorepository and storage | 24.0% | 24.6% | USD 942 mn | 9.3% |
| Packaging and temperature-control | 12.0% | 10.7% | USD 471 mn | 7.8% |
| Software and tracking | 10.0% | 11.8% | USD 392 mn | 10.8% |
By temperature
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Ambient | 20.0% | 15.8% | USD 785 mn | 6.4% |
| Refrigerated 2-8C | 42.0% | 39.9% | USD 1.6 bn | 8.4% |
| Frozen | 24.0% | 26.1% | USD 942 mn | 9.9% |
| Cryogenic | 14.0% | 18.3% | USD 549 mn | 11.9% |
By end user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Pharma and biotech trials | 52.0% | 54.7% | USD 2.0 bn | 9.6% |
| Diagnostic laboratories | 24.0% | 22.0% | USD 942 mn | 8.1% |
| Biobanks and research | 14.0% | 14.1% | USD 549 mn | 9.1% |
| Hospitals and others | 10.0% | 9.2% | USD 392 mn | 8.1% |
By specimen
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Blood and plasma | 36.0% | 34.0% | USD 1.4 bn | 8.4% |
| Tissue | 20.0% | 20.0% | USD 785 mn | 9.0% |
| Urine and stool | 14.0% | 14.0% | USD 549 mn | 9.0% |
| Cell and DNA samples | 30.0% | 32.0% | USD 1.2 bn | 9.7% |
By sample purpose
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Clinical trials | 46.0% | 46.0% | USD 1.8 bn | 9.0% |
| Routine diagnostics | 30.0% | 28.0% | USD 1.2 bn | 8.2% |
| Biobanking and research | 24.0% | 26.0% | USD 942 mn | 9.9% |
Top 25 countries for biospecimen logistics by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 87.0% of 2026 revenue and the 25 countries below together hold 97.0%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 1.6 bn | 42.0% | USD 3.7 bn | 8.5% |
| 2 | Germany | USD 314 mn | 8.0% | USD 706 mn | 8.4% |
| 3 | United Kingdom | USD 275 mn | 7.0% | USD 650 mn | 9.0% |
| 4 | China | USD 275 mn | 7.0% | USD 855 mn | 12.0% |
| 5 | France | USD 196 mn | 5.0% | USD 446 mn | 8.6% |
| 6 | Japan | USD 196 mn | 5.0% | USD 418 mn | 7.9% |
| 7 | Canada | USD 157 mn | 4.0% | USD 372 mn | 9.0% |
| 8 | Switzerland | USD 118 mn | 3.0% | USD 251 mn | 7.9% |
| 9 | India | USD 118 mn | 3.0% | USD 399 mn | 13.0% |
| 10 | Spain | USD 118 mn | 3.0% | USD 279 mn | 9.0% |
| 11 | Belgium | USD 67 mn | 1.7% | USD 153 mn | 8.7% |
| 12 | Netherlands | USD 60 mn | 1.5% | USD 138 mn | 8.7% |
| 13 | Singapore | USD 54 mn | 1.4% | USD 138 mn | 9.9% |
| 14 | Italy | USD 44 mn | 1.1% | USD 102 mn | 8.7% |
| 15 | Australia | USD 32 mn | 0.8% | USD 73 mn | 8.7% |
| 16 | Sweden | USD 24 mn | 0.6% | USD 56 mn | 8.8% |
| 17 | South Korea | USD 20 mn | 0.5% | USD 52 mn | 10.0% |
| 18 | Denmark | USD 20 mn | 0.5% | USD 46 mn | 8.8% |
| 19 | Brazil | USD 18 mn | 0.5% | USD 46 mn | 9.9% |
| 20 | Taiwan | USD 15 mn | 0.4% | USD 38 mn | 10.1% |
| 21 | Austria | USD 10 mn | 0.3% | USD 24 mn | 9.0% |
| 22 | Mexico | USD 9.4 mn | 0.2% | USD 24 mn | 9.9% |
| 23 | Poland | USD 8.2 mn | 0.2% | USD 21 mn | 10.0% |
| 24 | Israel | USD 7.1 mn | 0.2% | USD 16 mn | 8.4% |
| 25 | Turkey | USD 5.9 mn | 0.1% | USD 15 mn | 9.7% |
| Rest of world | USD 117 mn | 3.0% | USD 255 mn | 8.1% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- World Courier
- Marken
- DHL Global Forwarding
- FedEx
- Kuehne+Nagel
- DSV
Group 2: Regional and specialist players
- Cryoport
- Azenta
- Biocair
- QuickSTAT
- Yourway
- Fisher BioServices
- Medspeed
- Movianto
Group 3: Emerging and niche players
- Ancillare
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the biospecimen logistics market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 9.0% is calculated from the resulting values.
The market is divided by service, by temperature, by end user, by specimen, by sample purpose. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the biospecimen logistics market?
The global biospecimen logistics market is estimated at USD 3.6 bn in 2025 and USD 3.9 bn in 2026.
How fast will the biospecimen logistics market grow?
It is forecast to reach USD 9.3 bn by 2036, a compound annual growth rate of 9.0% from 2026, an increase of USD 5.4 bn.
Which country is the largest market for biospecimen logistics?
United States is the largest market by revenue at USD 1.6 bn in 2026, 42.0% of the global total. The three largest countries together hold 57.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 13.0% a year from 2026 to 2036.
Which biospecimen logistics segment is largest?
In the by service split, Transport and courier is the largest segment with 54.0% of 2026 revenue.
Who are the leading biospecimen logistics companies?
Global leaders include World Courier, Marken, DHL Global Forwarding, FedEx.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Behavioral Health Continuum SolutionsUSD 4.0 bn · 10.5% CAGR
- Nuclear MedicineUSD 4.0 bn · 6.2% CAGR
- Lower Limb Arterial Disease ManagementUSD 4.1 bn · 7.2% CAGR
- Pharmaceutical SerializationUSD 3.7 bn · 9.0% CAGR
- AutoinjectorUSD 3.7 bn · 10.0% CAGR
- ImmunohistochemistryUSD 3.5 bn · 8.0% CAGR
- Healthcare Provider Workflow OptimizationUSD 3.4 bn · 10.5% CAGR
- CapsuleUSD 3.4 bn · 6.5% CAGR